Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Highland Hospital
HCP 5 GI LAB
Oakland, CA 94602
Education & Training
University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 2005 - 2009
University of MichiganResidency, Internal Medicine, 2001 - 2004
University of Texas Medical Branch School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2012 - 2026
TX State Medical License 2006 - 2013
MI State Medical License 2001 - 2008- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 82 citationsRace/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.John Ha, Melissa Yan, Maria Aguilar, Taft Bhuket, Michele M. Tana
Cancer. 2016-08-15 - 7 citationsLower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals.Kellie Young, Benny Liu, Taft Bhuket, Robert J. Wong
Journal of Clinical and Experimental Hepatology. 2020-02-21 - 20 citationsA Comprehensive Analysis of Liver Transplantation Outcomes Among Ethnic Minorities in the United States.Dharmesh H. Kaswala, Julia Zhang, Andy Liu, Vinay Sundaram, Benny Liu
Journal of Clinical Gastroenterology. 2020-03-01
Press Mentions
Cyclo Therapeutics Announces Positive Efficacy Data from Extension Protocol with Trappsol® Cyclo™ in Patients with Niemann-Pick Disease Type CJanuary 5th, 2021
Cyclo Therapeutics Inc. Announces Positive Top Line Results from Phase I Trial and Interim Analysis of Phase I/II Trial Using Trappsol® Cyclo™ Intravenously to Treat Patients with Niemann-Pick Disease Type C1 (NPC1)May 20th, 2020- Last Patient Last Visit in Cyclo Therapeutics’ Phase I Trial in Niemann-Pick Type CFebruary 11th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
